Takotsubo syndrome can be the initial presentation of a subclinical titin cardiomyopathy, highlighting the need for appropriate anti-arrhythmic therapy due to the risk of sudden cardiac death.
Answers are grounded in this paper and cite their sources.
Alerts to arrhythmia risk in titin cardiomyopathy presenting as Takotsubo; leaves open whether genetic evaluation improves outcomes.
previously subclinical CMP may initially manifest as TTS. Since patients with titin CMP are at risk of developing ventricular arrhythmias and thus to experience sudden cardiac death, appropriate anti-arrhythmic therapy needs to be established.
No takes yet. Share an insight, caveat, or question.
Keller et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: